OwnershipPublicly listed · Nasdaq: CLPTSEC EDGAR company record and tickers file (Nasdaq: CLPT) · checked Oct 28, 2026
Commercial developmentNot yet assessedWe only state a stage once a source supports it. Having a product on sale does not show it works or makes money.
Investment accessVerified public listingListed as Nasdaq: CLPT, per the SEC's company tickers file. A listing means shares trade publicly; it says nothing about whether they are a good investment.Source · checked Oct 28, 2026

Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Next scheduled recheck: Nov 27, 2026.

5developments published
$183,749US federal obligations on record
2private-offering notices since 2019
Oct 28, 2026latest development

Timeline

  1. Oct 28, 2026 · Reported results

    ClearPoint Neuro Reports Third Quarter 2026 Results

    Company-reported
  2. Aug 3, 2026 · Reported results

    ClearPoint Neuro Reports Second Quarter 2026 Results

    Company-reported
  3. May 20, 2026 · Leadership change

    ClearPoint Neuro reports changes involving its directors or officers (Form 8-K, Item 5.02)

    Regulatory filing
  4. May 13, 2026 · Reported results

    ClearPoint Neuro Reports First Quarter 2026 Results

    Company-reported
  5. Feb 5, 2026 · Private financing (Form D)

    ClearPoint Neuro reports $17.9 million of equity sold in a private offering

    Regulatory filing

Profile

Legal name
ClearPoint Neuro, Inc.
Listing
Nasdaq CLPT
SEC industry code
Surgical & Medical Instruments & Apparatus
Incorporated
DE
Coverage
Filings + federal awards

Watch ClearPoint Neuro

Anything new from ClearPoint Neuro lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.

Follow this companyPreview a sample digest

Private offerings reported to the SEC (Form D)

A Form D is a notice a company files after selling securities without a public registration. Amount sold is cumulative for that offering as reported by the company; an amendment (D/A) updates an earlier notice, so rows are not added together. None of these is a valuation or an open offer.

FiledFormAmount soldOffering sizeFirst saleInvestorsExemptionRecord
Feb 5, 2026D$17.9 million$17.9 millionNov 20, 202546Rule 506(b)SEC ↗
May 29, 2019D$7.5 million$7.5 millionMay 17, 201917Rule 506(b)SEC ↗

US federal awards

From USAspending.gov. Obligated is money the government has committed, not company revenue and not the contract’s potential ceiling. Outlays is what has actually been paid. Totals: $183,749 obligated, $0.00 paid out across 2 awards.

AgencyDescriptionObligatedPaid outPeriodRecord
Department of Veterans AffairsCLEARPOINT NEURO WORKSTATION$183,749Not statedAug 12, 2024 – Aug 11, 2025USAspending ↗
National Institutes of HealthMRI INTERVENTIONS INC:1232027 [18-012644]$0.00$0.00Jul 23, 2018 – Sep 11, 2024USAspending ↗